Business Context and Reporting Period
This Form 8-K was filed by OncoGenex Pharmaceuticals, Inc. on March 7, 2013. The report announces the financial results for the fourth quarter and the full year ended December 31, 2012. Note: The metadata provided lists "ACHIEVE LIFE SCIENCES, INC.", but the filing text explicitly identifies the registrant as OncoGenex Pharmaceuticals, Inc.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not contain specific data regarding material changes versus the prior comparable period. It serves solely as a notification that the results for the fourth quarter and year ended December 31, 2012, have been issued.
Guidance, Outlook, and Risks
The text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. The information regarding these topics is located in the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) in the press release dated March 7, 2013 (Exhibit 99.1).
- Confirm the company name discrepancy between the metadata (Achieve Life Sciences) and the filing (OncoGenex Pharmaceuticals).
- Review the full press release for any forward-looking statements or risk factors not summarized in this 8-K.